Coates, L., Garrood, T., Gullick, N., Helliwell, P., Kent, T., Marks, J., . . . McInnes, I. (2022). Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PSA-1 and SELECT-PsA-2 trials assessed according to modified PsARC. Oxford University Press.
توثيق أسلوب شيكاغو (الطبعة السابعة عشر)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)Coates, LC, et al. Upadacitinib Response Rates in Patients with Psoriatic Arthritis Enrolled in the SELECT-PSA-1 and SELECT-PsA-2 Trials Assessed According to Modified PsARC. Oxford University Press, 2022.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.